Practical Perspectives in the Treatment of Small-Cell Lung Cancer
EP. 1: IMpower133 and CASPIAN Trials for Extensive Stage SCLC
ByMark A. Socinski, MD, AdventHealth Cancer Institute,Roy S. Herbst, MD, PhD, Yale Cancer Center,Stephen Liu, MD, MedStar Georgetown University Hospital,Kristin Higgins, MD 
EP. 2: KEYNOTE-604 and ECOG-ACRIN 5161 Trials for ES-SCLC
ByMark A. Socinski, MD, AdventHealth Cancer Institute,Roy S. Herbst, MD, PhD, Yale Cancer Center,Stephen Liu, MD, MedStar Georgetown University Hospital,Kristin Higgins, MD 
EP. 3: Expert Approaches to Treating Extensive Stage SCLC
ByMark A. Socinski, MD, AdventHealth Cancer Institute,Roy S. Herbst, MD, PhD, Yale Cancer Center,Stephen Liu, MD, MedStar Georgetown University Hospital,Kristin Higgins, MD 
EP. 4: Role of PCI Versus Brain MRI Surveillance in ES-SCLC
ByMark A. Socinski, MD, AdventHealth Cancer Institute,Roy S. Herbst, MD, PhD, Yale Cancer Center,Stephen Liu, MD, MedStar Georgetown University Hospital,Kristin Higgins, MD 
EP. 5: Second- and Third-Line Treatment for ES-SCLC
ByMark A. Socinski, MD, AdventHealth Cancer Institute,Roy S. Herbst, MD, PhD, Yale Cancer Center,Stephen Liu, MD, MedStar Georgetown University Hospital,Kristin Higgins, MD 
EP. 6: Review of Treatment for Limited-Stage Small-Cell Lung Cancer
ByMark A. Socinski, MD, AdventHealth Cancer Institute,Roy S. Herbst, MD, PhD, Yale Cancer Center,Stephen Liu, MD, MedStar Georgetown University Hospital,Kristin Higgins, MD 